A detailed history of V Square Quantitative Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, V Square Quantitative Management LLC holds 1,138 shares of EXEL stock, worth $41,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,138
Holding current value
$41,184
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$21.96 - $27.6 $24,990 - $31,408
1,138 New
1,138 $29.5 Million
Q2 2023

Jul 26, 2023

BUY
$18.17 - $20.48 $8,903 - $10,035
490 New
490 $9.36 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track V Square Quantitative Management LLC Portfolio

Follow V Square Quantitative Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Square Quantitative Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Square Quantitative Management LLC with notifications on news.